Nhwehwɛmu foforo bi hui sɛ susuw . Mogya mu mframa pa a ɛwɔ fie no yɛ ɔkwan a ahobammɔ wom a nnipa a wɔwɔ covid-19 fa so hu nsɛnkyerɛnne a ɛkyerɛ sɛ wɔn akwahosan betumi asɛe. Pulse oximeters wɔ mmeae pii, mfiri a ne bo nyɛ den a ɛhyerɛn hann mu fa obi nsateaa mu de hwɛ sɛnea oxygen a ɛwɔ mogya mu no ayɛ ma. Adanse ada no adi sɛ oxygen dodow a ɛkɔ fam no yɛ ade titiriw a ɛkyerɛ sɛ ɔyarefo a ne ho yɛ den-19 akwahosan resɛe na ebia ebehia sɛ wɔhwɛ no yiye na wɔyɛ no ntɛm.
Nhwehwɛmu a wotintimii wɔ Lancet Digital Health mu no hwehwɛɛ nhwehwɛmu ahorow 13 a ɛkame ayɛ sɛ nnipa 3,000 na wɔde wɔn ho hyɛɛ mu wɔ aman anum mu *, a emu dodow no ara yɛɛ kɛse wɔ ɔyaredɔm a edi kan no mu.
Nyansahufo no hui sɛ sɛ wɔde aduruyɛ ho akwankyerɛ ma a, Home Pulse Oximetry betumi ayɛ adwuma sɛ ahobammɔ, na ɛbɛtew ntɛmpɛ ne ayaresabea a wɔde wɔn kɔ hɔ a ɛho nhia so ma ayarefo a wobetumi atra fie dwoodwoo, bere a wohu sɛnkyerɛnne ahorow a ɛkyerɛ ntɛm ara sɛ nneɛma asɛe ne ɔhwɛ a ɛrekɔ soro wɔ wɔn a wohia no mu. Eyi bɛboa ma wɔakora nneɛma a wɔatrɛw mu no so, na ɛbɛtew mmoawa no a wobetumi atrɛw mu bio afi nkitahodi mu wɔ akwahosan tebea horow mu.
Nanso, wɔn a wɔhwehwɛ nneɛma mu no hyɛ nhwehwɛmu a wɔayɛ wɔ ayarefo a wɔn honam ani yɛ tuntum a wɔn ho yɛ tuntum ho, a ebia oximetry nyɛ nea ɛyɛ pɛpɛɛpɛ sen aborɔfo de no nsow.
Nhwehwɛmufoɔ no gyina nea wɔahu no so de nyansahyɛ titire bi a ɛbɛtumi aboa ama wɔde oximetry a wɔde di dwuma wɔ Home Covid-19 nhwehwɛmu mu no ayɛ pɛpɛɛpɛ.
Nea ɛho hia no, nhwehwɛmu no kamfo kyerɛ sɛ wɔmfa beae a wɔatwa a wɔakyerɛkyerɛ mu wɔ . Oxygen dodow a ɛwɔ mogya mu (92%), a ɛbɛma akwahosan ho adwumayɛfo ahu bere a ɛsɛ sɛ ɔyarefo bi kɔ ayaresabea kɔhwɛ no, anaasɛ sɛ wobetumi ayi hia a ehia sɛ wɔhwɛ wɔn yiye saa bere no a.
Dr Ahmed Alboksmaty, nhwehwɛmu yɔnko a ofi Wiase Nyinaa Akwahosan Foforo Asoɛe no kae sɛ: 'Wɔ ɔyaredɔm no nyinaa mu no, ɔmanfo ho dadwen asesa afi ‘So manya covid?’. Sɛnea ɛbɛyɛ a ‘wɔbɛnya covid no, so ɛsɛ sɛ mekɔ ayaresabea?’.
'pulse oximetry yɛ mmerɛw sɛ wɔde bedi dwuma, ne bo yɛ den wɔ ɛho ka mu, ɛwɔ hɔ kɛse, na sɛnea yɛada no adi no, ɔkwan a mfaso wɔ so a yɛbɛfa so ahu akwahosan sɛe wɔ ayarefo a wɔyɛ covid-19 mu.'
Smartphone ne mobile app ahorow bi nso wɔ tumi a wɔde susuw oxygen dodow a ɛwɔ mogya mu, a nhwehwɛmufo no da no adi sɛ ɛyɛ adwinnade a wotumi de hwɛ nneɛma so kɛse. Nanso, bere a nhwehwɛmu ahorow bi abɔ amanneɛ sɛ ɛyɛ pɛpɛɛpɛ te sɛ atetesɛm mu ntini a ɛma mogya tu no, nhwehwɛmufo no de baa awiei sɛ adanse a ɛdɔɔso nni hɔ a ɛkyerɛ sɛ wonnya nkamfo nkyerɛ sɛ wɔmfa nni dwuma wɔ ayaresabea.
Nhwehwɛmu no nso kyerɛɛ nsonsonoe foforo a ɛwɔ mprempren adanse no mu, titiriw nsɛm a ɛdɔɔso a wɔde behu sɛ ebia pulse oximetry betumi ama akwahosan ho adwene a ɛwɔ hɔ ama ayarefo no atu mpɔn anaa.
Dr Ana Luisa Neves, Advanced Research Fellow from the Institute of Global Health Innovation, said: 'Our research has demonstrated how the use of pulse oximetry in remote patient monitoring could help ease the strains on health systems during the COVID-19 pandemic. However, it's vital to ensure that the current lack of research in racially and ethnically diverse populations is addressed. It's therefore critical to provide support to ensure this technology reduces, rather than entrenches, existing Akwahosan mu pɛyɛ a enni hɔ.
Sɛ wopɛ nsɛm pii a, yɛsrɛ wo kɔ . www.sejoygroup.com .
